Cargando…
Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study
INTRODUCTION: To compare the functional and anatomic outcomes between eyes in patients with diabetic macular edema (DME) who underwent a complete anti-vascular endothelial growth factor (VEGF) loading dose with aflibercept and those who were switched to dexamethasone intravitreal (DEX) implant after...
Autores principales: | Scorcia, Vincenzo, Giannaccare, Giuseppe, Gatti, Valentina, Vaccaro, Sabrina, Piccoli, Gabriele, Villì, Annarita, Toro, Mario Damiano, Yu, Angeli Christy, Iovino, Claudio, Simonelli, Francesca, Carnevali, Adriano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418689/ https://www.ncbi.nlm.nih.gov/pubmed/34482532 http://dx.doi.org/10.1007/s40123-021-00395-6 |
Ejemplares similares
-
Effectiveness of a Hydrophilic Curcumin-Based Formulation in Coadjuvating the Therapeutic Effect of Intravitreal Dexamethasone in Subjects With Diabetic Macular Edema
por: Parravano, Mariacristina, et al.
Publicado: (2022) -
Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19
por: Iovino, Claudio, et al.
Publicado: (2021) -
Intravitreal Injection Planning during COVID-19 Pandemic: A Retrospective Study of Two Tertiary University Centers in Italy
por: Mazzuca, Daniela, et al.
Publicado: (2023) -
Multimodal imaging of Hypotrichosis with juvenile macular dystrophy: a case report
por: Scalzo, Giovanna Carnovale, et al.
Publicado: (2021) -
Efficacy and Safety of Combined Vitrectomy with Intravitreal Dexamethasone Implant for Advanced Stage Epiretinal Membrane
por: Iovino, Claudio, et al.
Publicado: (2019)